UGAZ Nat Gas Leveraged ETF +5% in our Friday Trade
by Mike Paulenoff
July 1, 2017 • 12:00 AM EDT
Last week we noted our 5.6% trade in the SPDR S&P Biotech ETF (XBI). We continued to be bullish on the XBI, and had a target of 79-80.
This week the XBI met our target and then some, reaching 80.89 before closing the week at 77.18.
There's a risk down to the recent upside breakout in the 73-71 area at some point, which, if it contains the weakness, could provide the launchpad for a thrust towards 100 in the very big picture.
Another sector we follow closely is Natural Gas. On Tuesday of this week we told our members to watch for movement off of Wednesday's release of weekly Nat Gas inventories.
We noted that the release could trigger a downside stop-fest that presses Nat Gas back under 3.00, into the 2.90 area support, where my work argues in favor of establishing or adding new long positions ahead of upside potential again into the 3.30-3.40 target zone.
On Wednesday's release, Nat Gas initially popped to challenge June resistance at 3.10-3.11, but stalled there and a bit later in the session pivoted to the downside into a nosedive that violated nearest term support at 3.066.
As it dropped towards our preferred support area, we added a position in the VelocityShares 3x Long Natural Gas ETN (UGAZ) on Friday at 13.17. By the close, the UGAZ was at 13.82, giving us a +5% yield on our trade for the day.
Have a great weekend!
Mike Paulenoff is the author of MPTrader.com, a real-time diary of his technical analysis & trade alerts on
ETFs for precious metals, energy, currencies, and an array of equity indices and sectors, including international
markets, plus key ETF component stocks in sectors like technology, mining, and banking.
Sign up for a Free 7-day Trial!
More Top Calls From Mike
Nearly two months ago, I posted my technical setup on TMO (Thermo Fisher Scientific, Inc.) to alert MPTrader members to a potentially significant upside reversal pattern. Here is my commentary from June 3, 2025:My attached Big Picture Daily Chart shows the major bear phase from the 9/10/24 ATH at 627.88 to last week's (5/23/25) low at 390.66 (-38%). Most interestingly, all of the price action from the 4/09/25 low at 409.
Every person on the planet is now aware that early on Saturday night, June 21st, 2025, the U.S. military attacked and severely damaged (destroyed?) Iran's nuclear sites and presumably their ability to produce nuclear materials needed to create a WMD.
Last Wednesday afternoon (6/11/25), with META circling 700 after establishing a 4-month new post-April 2025 recovery rally high at 708.87, this is what we discussed about the current technical setup: Just a heads up that my pattern work is warning me that the 52% upmove from the 4/07 low at 467.31 to today's (6/11) high at 708.87 has the right look of a completed, overextended, overbought, unconfirmed rally peak that leaves the price structure vulnerable to a correction of some magnitude.
On May 6, 2025, during the final hour of trading, and before AMD was scheduled to report quarterly Earnings that evening, I posted the following analysis to our MPTrader Discussion Room:AMD reports Earnings after the close... The only conviction I can derive from my pattern work is that the 4/08/25 low at 76.48, which represented a 66% correction from the March 2024 high at 227.30, has the right look of a significant low that completed a major bear phase.
On April 22, 2025, I posted the following analysis about my technical setup work in XBI (SPDR SP Biotech ETF):XBI (SPDR SP Biotech ETF)-- Could it be? Could it be that the near-40% correction from the 11/11/24 multi-year high at 105.47 to the 4/09/25 low at 66.66 fully discounted all the bad news in this sector? From a BIG Picture perspective, my attached Daily Chart shows this month's spike low into the vicinity of the previous major corrective low-zone starting in May 2022.